Clinical and Translational Oncology

, 11:715

Role of transforming growth factor β in cancer microenvironment

  • Luis de la Cruz-Merino
  • Fernando Henao-Carrasco
  • Teresa García-Manrique
  • Pedro M. Fernández-Salguero
  • Manuel Codes-Manuel de Villena
Educational Series Molecular Targets in Oncology

DOI: 10.1007/s12094-009-0433-8

Cite this article as:
de la Cruz-Merino, L., Henao-Carrasco, F., García-Manrique, T. et al. Clin Transl Oncol (2009) 11: 715. doi:10.1007/s12094-009-0433-8

Abstract

Transforming growth factor β (TGF-β) family members are polypeptidic cytokines with pleiotropic physiological properties. In relation to cancer, TGF-β exerts a dual tumour-suppressive and oncogenic effect, which is largely dependent on microenvironment stimuli. After activation of TGF-β signalling, two pathways can be activated: the canonical one through the mammalian Smad family or the non-canonical one activating, among others, the cellular mitogen-activated protein kinase (MAPK) signalling downstream, which interacts with Smad signalling. During tumorigenesis, cells of many cancer types often lose their response to the tumour-suppressive effects of TGF-β, which, in turn, has the opposite effect, acting as an autocrine tumour-promoting factor. In this review, we summarise the current knowledge about this intriguing cytokine, with special emphasis on its immunosuppressive actions.

Keywords

Transforming growth factorCancerMicroenvironment

Copyright information

© Feseo 2009

Authors and Affiliations

  • Luis de la Cruz-Merino
    • 1
  • Fernando Henao-Carrasco
    • 1
  • Teresa García-Manrique
    • 1
  • Pedro M. Fernández-Salguero
    • 2
  • Manuel Codes-Manuel de Villena
    • 1
  1. 1.Servicio de Oncología MédicaHospital Universitario Virgen MacarenaSevillaSpain
  2. 2.Departamento de Bioquímica y Biología Molecular Facultad de CienciasUniversidad de ExtremaduraBadajozSpain